SEARCH VEGSOURCE:

 

 

Follow Ups | Post Followup | Back to Discussion Board | VegSource
See spam or
inappropriate posts?
Please let us know.
  




From: TSS ()
Subject: FDA FSIS APHIS FEDERAL DOCKET BSE CJD MAD COW COMMENTERS SILENCED SINCE THE 7 1/2 SCIENTISTS, McDonald's, SEROLOGICALS CORPORATION, PUBLIC POSTINGS ?
Date: January 2, 2007 at 9:35 am PST

In Reply to: FDA FSIS APHIS FEDERAL DOCKET BSE CJD MAD COW COMMENTERS SILENCED SINCE THE 7 1/2 SCIENTISTS, McDonald's, SEROLOGICALS CORPORATION, PUBLIC POSTINGS ? posted by TSS on October 18, 2006 at 1:01 pm:

2006N-0472 Agency Information Collection Activities; Proposed Collection; Comment Request; Substances Prohibited from Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed



N 1 FDA Vol #: 1

Dockets Entered On December 4, 2006

[Federal Register: December 4, 2006 (Volume 71, Number 232)]
[Notices]
[Page 70409-70410]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04de06-66]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2006N-0472]


Agency Information Collection Activities; Proposed Collection;
Comment Request; Substances Prohibited from Use in Animal Food or Feed;
Animal Proteins Prohibited in Ruminant Feed

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments on extending OMB approval on the
existing recordkeeping requirements for this information collection,
regarding animal proteins prohibited in ruminant feed.

DATES: Submit written or electronic comments on the collection of
information by February 2, 2007.

ADDRESSES: Submit electronic comments on the collection of information
to: http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/dockets/ecomments. Submit written comments on

the collection of information to the Division of Dockets Management
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket
number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of the
Chief Information Officer (HFA-250), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-827-1472.

SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

Substances Prohibited From Use in Animal Food or Feed; Animal Proteins
Prohibited in Ruminant Feed--21 CFR 589.2000(e)(1)(iv) (OMB Control
Number 0910-0339)--Extension

This information collection was established because epidemiological
evidence gathered in the United Kingdom suggested that bovine
spongiform encephalopathy (BSE), a progressively degenerative central
nervous system disease, is spread to ruminant animals by feeding
protein derived from ruminants infected with BSE. This regulation
places general requirements on persons that manufacture, blend,
process, and

[[Page 70410]]

distribute products that contain or may contain protein derived from
mammalian tissue, and feeds made from such products.
The respondents for this collection of information are
manufacturers and or distributors of products that contain or may
contain protein derived from mammalian tissues and feeds made from such
products.
FDA estimates the burden of this collection of information as
follows:

Table 1.--Estimated Annual Recordkeeping Burden\1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
No. of Annual Frequency Total Annual
21 CFR Section Recordkeepers per Recordkeeping Records Hours per Record Total Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
589.2000 (e)(1)(iv) 400 1 400 14 5,600
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\There are no capital costs or operating and maintenance costs associated with this collection of information.


Dated: November 28, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy
[FR Doc. E6-20476 Filed 12-01-06; 8:45 am]

BILLING CODE 4160-01-S


http://www.fda.gov/OHRMS/DOCKETS/98fr/E6-20476.htm





Follow Ups:



Post a Followup

Name:
E-mail: (optional)
Subject:

Comments:

Optional Link URL:
Link Title:
Optional Image URL: